In 2003, two quirky scientists vowed to make the world a better place. After learning their trades in some of the world’s biggest scientific organisations, Paul and Mark Davis (father and son team with a striking resemblance to Pinky and the Brain established Mologic to do as much good as possible in healthcare and education. They want to improve patient care and quality of life, and break new ground in exciting fields of research (unlike Pinky and the Brain who wanted to take over the world).
Location: United Kingdom, England, Thurleigh
Member count: 51-200
Phone: +44 1234 780020
Total raised: $9.392752M
Founded date: 2003
Investors 1
| Date | Name | Website |
| 19.01.2021 | Foresight ... | foresightg... |
Funding Rounds 2
| Date | Series | Amount | Investors | Deal News |
| 26.12.2016 | Grant | $4.8M | - | tech.eu/br... |
| 27.10.2015 | - | $4.592752M | - | finsmes.co... |
Mentions in press and media 28
| Date | Title | Description | Source |
| 20.07.2021 | Bill Gates and a consortium of investors are buying UK Covid... | With more than one and a half-year into the fight against the deadly coronavirus, many are wondering... | techstartu... |
| 19.07.2021 | Months after Amgen's landmark KRAS approval, Chris Varm... | For years, mutant, cancer-fueling KRAS proteins were considered “undruggable.” That all cha... | endpts.com... |
| 19.07.2021 | Soros, Gates back medtech's move into a 'social enterpri... | George Soros and Bill Gates are teaming up to buy out a British diagnostics company. The pair... | endpts.com... |
| 19.07.2021 | FDA’s domestic biopharma inspections return to norma... | For the first time since March 2020, the FDA’s inspections of US-based biopharma sites have ret... | endpts.com... |
| 19.07.2021 | FDA’s domestic biopharma inspections return to norma... | Merck has crossed the FDA finish line with its next-generation pneumococcal vaccine, succeeding in i... | endpts.com... |
| 19.07.2021 | FDA’s domestic biopharma inspections return to norma... | After losing a whole lot of market confidence in their lead drug, little Cytokinetics is now lining ... | endpts.com... |
| 19.07.2021 | Months after Amgen's landmark KRAS approval, Chris Varm... | Tillman Gerngross doesn’t waffle. The longtime Dartmouth professor and Adimab founder tends to pick... | endpts.com... |
| 19.07.2021 | IPOs continue to bustle as three more biotechs prepare t... | Editor’s note: Interested in following biopharma’s fast-paced IPO market? You can bookmar... | endpts.com... |
| 19.07.2021 | Covid-19 roundup: FDA formally hands Pfizer/BioNTech's v... | The FDA said last Friday that it would give an expedited look at the Pfizer-BioNTech vaccine ... | endpts.com... |
| 19.07.2021 | Merck KGaA fortifies its ‘site of the future’ with $319M... | Everything began in 1668, in Darmstadt, Germany — so goes Merck KGaA’s description of its glo... | endpts.com... |
Show more